Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition.

The increasing resistance to current therapeutic agents for HIV drug regiment remains a major problem for effective acquired immune deficiency syndrome (AIDS) therapy. Many potential inhibitors have today been developed which inhibits key cellular pathways in the HIV cycle. Inhibition of HIV-1 rever...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vasanthanathan Poongavanam, Jacob Kongsted
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/84269d3c014041e0be86253cb4cb92c4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:84269d3c014041e0be86253cb4cb92c4
record_format dspace
spelling oai:doaj.org-article:84269d3c014041e0be86253cb4cb92c42021-11-18T08:55:13ZVirtual screening models for prediction of HIV-1 RT associated RNase H inhibition.1932-620310.1371/journal.pone.0073478https://doaj.org/article/84269d3c014041e0be86253cb4cb92c42013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24066050/?tool=EBIhttps://doaj.org/toc/1932-6203The increasing resistance to current therapeutic agents for HIV drug regiment remains a major problem for effective acquired immune deficiency syndrome (AIDS) therapy. Many potential inhibitors have today been developed which inhibits key cellular pathways in the HIV cycle. Inhibition of HIV-1 reverse transcriptase associated ribonuclease H (RNase H) function provides a novel target for anti-HIV chemotherapy. Here we report on the applicability of conceptually different in silico approaches as virtual screening (VS) tools in order to efficiently identify RNase H inhibitors from large chemical databases. The methods used here include machine-learning algorithms (e.g. support vector machine, random forest and kappa nearest neighbor), shape similarity (rapid overlay of chemical structures), pharmacophore, molecular interaction fields-based fingerprints for ligands and protein (FLAP) and flexible ligand docking methods. The results show that receptor-based flexible docking experiments provides good enrichment (80-90%) compared to ligand-based approaches such as FLAP (74%), shape similarity (75%) and random forest (72%). Thus, this study suggests that flexible docking experiments is the model of choice in terms of best retrieval of active from inactive compounds and efficiency and efficacy schemes. Moreover, shape similarity, machine learning and FLAP models could also be used for further validation or filtration in virtual screening processes. The best models could potentially be use for identifying structurally diverse and selective RNase H inhibitors from large chemical databases. In addition, pharmacophore models suggest that the inter-distance between hydrogen bond acceptors play a key role in inhibition of the RNase H domain through metal chelation.Vasanthanathan PoongavanamJacob KongstedPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e73478 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Vasanthanathan Poongavanam
Jacob Kongsted
Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition.
description The increasing resistance to current therapeutic agents for HIV drug regiment remains a major problem for effective acquired immune deficiency syndrome (AIDS) therapy. Many potential inhibitors have today been developed which inhibits key cellular pathways in the HIV cycle. Inhibition of HIV-1 reverse transcriptase associated ribonuclease H (RNase H) function provides a novel target for anti-HIV chemotherapy. Here we report on the applicability of conceptually different in silico approaches as virtual screening (VS) tools in order to efficiently identify RNase H inhibitors from large chemical databases. The methods used here include machine-learning algorithms (e.g. support vector machine, random forest and kappa nearest neighbor), shape similarity (rapid overlay of chemical structures), pharmacophore, molecular interaction fields-based fingerprints for ligands and protein (FLAP) and flexible ligand docking methods. The results show that receptor-based flexible docking experiments provides good enrichment (80-90%) compared to ligand-based approaches such as FLAP (74%), shape similarity (75%) and random forest (72%). Thus, this study suggests that flexible docking experiments is the model of choice in terms of best retrieval of active from inactive compounds and efficiency and efficacy schemes. Moreover, shape similarity, machine learning and FLAP models could also be used for further validation or filtration in virtual screening processes. The best models could potentially be use for identifying structurally diverse and selective RNase H inhibitors from large chemical databases. In addition, pharmacophore models suggest that the inter-distance between hydrogen bond acceptors play a key role in inhibition of the RNase H domain through metal chelation.
format article
author Vasanthanathan Poongavanam
Jacob Kongsted
author_facet Vasanthanathan Poongavanam
Jacob Kongsted
author_sort Vasanthanathan Poongavanam
title Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition.
title_short Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition.
title_full Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition.
title_fullStr Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition.
title_full_unstemmed Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition.
title_sort virtual screening models for prediction of hiv-1 rt associated rnase h inhibition.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/84269d3c014041e0be86253cb4cb92c4
work_keys_str_mv AT vasanthanathanpoongavanam virtualscreeningmodelsforpredictionofhiv1rtassociatedrnasehinhibition
AT jacobkongsted virtualscreeningmodelsforpredictionofhiv1rtassociatedrnasehinhibition
_version_ 1718421150255546368